211 related articles for article (PubMed ID: 27222277)
1. Inverse psoriasis treated with ustekinumab.
Campos MA; Varela P; Baptista A; Moreira AI
BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27222277
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of severe psoriasis in an adolescent with ustekinumab.
AbuHilal M; Ho N
Pediatr Dermatol; 2015; 32(3):377-80. PubMed ID: 25727845
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis.
Rouse NC; Farhangian ME; Wehausen B; Feldman SR
Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):877-84. PubMed ID: 26488186
[TBL] [Abstract][Full Text] [Related]
4. Refractory Palmoplantar Pustular Psoriasis Treated With High-Dose Ustekinumab After Initial Failure.
Bohdanowicz M; Sajic D
J Cutan Med Surg; 2019; 23(1):102-104. PubMed ID: 30141337
[TBL] [Abstract][Full Text] [Related]
5. Ustekinumab in the treatment of palmoplantar pustular psoriasis - a case series of nine patients.
Buder V; Herberger K; Jacobi A; Augustin M; Radtke MA
J Dtsch Dermatol Ges; 2016 Nov; 14(11):1108-1113. PubMed ID: 27879067
[TBL] [Abstract][Full Text] [Related]
6. Excellent response to ustekinumab in a 9-year-old girl with severe psoriasis.
González-Barreto RM; Rochet NM; Nevares-Pomales OW; Colón-Fontanez F
Pediatr Dermatol; 2018 Jan; 35(1):e76-e78. PubMed ID: 29205479
[TBL] [Abstract][Full Text] [Related]
7. Correlation Between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis Treated with Ustekinumab.
Hesselvig JH; Egeberg A; Loft ND; Zachariae C; Kofoed K; Skov L
Acta Derm Venereol; 2018 Mar; 98(3):335-339. PubMed ID: 29110019
[TBL] [Abstract][Full Text] [Related]
8. Ocular toxoplasmosis in a patient treated with ustekinumab for psoriasis.
Javadzadeh S; Gkini MA; Panos GD; Adewoyin T; Bewley A
Clin Exp Dermatol; 2020 Aug; 45(6):802-804. PubMed ID: 32212270
[No Abstract] [Full Text] [Related]
9. Dose Modification in Biologic Therapy for Moderate to Severe Psoriasis: A Descriptive Analysis in a Clinical Practice Setting.
Baniandrés O; Rodríguez-Soria VJ; Romero-Jiménez RM; Suárez R
Actas Dermosifiliogr; 2015 Sep; 106(7):569-77. PubMed ID: 25935194
[TBL] [Abstract][Full Text] [Related]
10. Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis.
Augustin M; Blome C; Paul C; Puig L; Luger T; Lambert J; Chimenti S; Girolomoni G; Kragballe K; Naessens D; Bergmans P; Smirnov P; Barker J; Reich K
J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):294-303. PubMed ID: 27515070
[TBL] [Abstract][Full Text] [Related]
11. Acrodermatitis continua of Hallopeau response to optimized biological therapy.
Adas A; Dadban A; Arnault JP; Chaby G; Lok C
Dermatol Online J; 2019 Feb; 25(2):. PubMed ID: 30865417
[TBL] [Abstract][Full Text] [Related]
12. Biologic drug survival in Israeli psoriasis patients.
Shalom G; Cohen AD; Ziv M; Eran CB; Feldhamer I; Freud T; Berman E; Oren S; Hodak E; Pavlovsky L
J Am Acad Dermatol; 2017 Apr; 76(4):662-669.e1. PubMed ID: 28038888
[TBL] [Abstract][Full Text] [Related]
13. Long-term therapy with ustekinumab for psoriasis in a patient with a history of malignant melanoma.
Gkalpakiotis S; Arenberger P; Fridman M; Arenbergerova M
Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28730674
[No Abstract] [Full Text] [Related]
14. Psoriasis: the new and the old.
Feldman SR
J Drugs Dermatol; 2014 Aug; 13(8):894. PubMed ID: 25116962
[No Abstract] [Full Text] [Related]
15. The Association between Clinical Response to Ustekinumab and Immunogenicity to Ustekinumab and Prior Adalimumab.
Chiu HY; Chu TW; Cheng YP; Tsai TF
PLoS One; 2015; 10(11):e0142930. PubMed ID: 26566272
[TBL] [Abstract][Full Text] [Related]
16. Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in a Psoriasis Patient Treated With Ustekinumab.
Dickson L; Menter A
J Drugs Dermatol; 2017 Feb; 16(2):177-179. PubMed ID: 28300862
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
[No Abstract] [Full Text] [Related]
18. Ustekinumab treatment in patients with psoriasis undergoing hemodialysis.
Umezawa Y; Hayashi M; Kikuchi S; Fukuchi O; Yanaba K; Ito T; Asahina A; Saeki H; Nakagawa H
J Dermatol; 2015 Jul; 42(7):731-4. PubMed ID: 25959602
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of ustekinumab treatment in elderly patients with psoriasis.
Hayashi M; Umezawa Y; Fukuchi O; Ito T; Saeki H; Nakagawa H
J Dermatol; 2014 Nov; 41(11):974-80. PubMed ID: 25346301
[TBL] [Abstract][Full Text] [Related]
20. Ustekinumab in Real-Life Practice: Experience in 116 Patients with Moderate-To-Severe Psoriasis.
Raposo I; Bettencourt A; Leite L; Selores M; Torres T
Acta Med Port; 2019 Mar; 32(3):214-218. PubMed ID: 30946793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
